Image

Determination of the Minimal Detectable Change of the Parkinson's Disease Questionnaire-8

Determination of the Minimal Detectable Change of the Parkinson's Disease Questionnaire-8

Recruiting
40-80 years
All
Phase N/A

Powered by AI

Overview

This study is conducted to determine how many units of improvement the Parkinson's Disease Questionnaire-8 (PDQ-8), used to evaluate the quality of life of Parkinson's patients, should have to express a significant change in the quality of life. Patients for whom a 30-session physiotherapy program is recommended will be included in the study. Patients will be asked to express the change in their quality of life at the end of treatment. The PDQ-8 survey and Global Rating of Patient-Perceived Changes (GRP-PC) forms will be used to determine these changes. Evaluations will be repeated at the beginning of the treatment program and at the end of the 30th session.

Eligibility

Inclusion Criteria:

  • Having regular neurology follow-up and using medicine;
  • Hoehn and Yahr Scale Stage between 1-3 points;
  • Mini-Mental State Assessment Score >24 points;

Exclusion Criteria:

  • Having a secondary neurological disease;
  • Any surgery and/or trauma affecting the upper extremity
  • Having complaints of pain before the treatment program;
  • There was a change in medical treatment during the study;
  • With symptoms of anxiety and depression;
  • Those who use alcohol and drugs;
  • Individuals with vision defects that cannot be corrected by the use of glasses and those with hearing loss

Study details
    Parkinson Disease

NCT06487364

Emre Şenocak

21 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.